SCHEMBL6654552

SCHEMBL6654552

Cc1[nH]c2ccc(CCN3CC4CC3CO4)cc2c1C(=O)OCc1ccccc1.Cc1[nH]c2ccc(CCOS(C)(=O)=O)cc2c1C(=O)OCc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
GAA P10253 2/20 0.35
ALOX5 P09917 3/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KMT2A Q03164 2/20 0.34
KCNH2 Q12809 1/20 0.33
MCHR1 Q99705 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315948 0.93 GAA (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6316385 0.83 GAA (0.49) GAAALOX5NPC1RAB9AKMT2A
SCHEMBL6659460 0.80 GAA (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6654086 0.80 ALDH1A1 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6651182 0.80 DRD2 (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6649651 0.77 CCR5 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6315446 0.74 GAA (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6314397 0.74 HRH3 (0.51) KCNH2ALDH1A1
SCHEMBL6316026 0.73 GAA (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6316042 0.73 GAA (0.47) GAAALOX5NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2004-01-07 EP disclosed
WO-2002072549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-09-19 WO disclosed